Group 1 - Avanos Medical, Inc. (NYSE: AVNS) is perceived as undervalued due to its expanding international presence and aggressive M&A strategy [1] - The company operates in growth target markets, particularly the neonatal enteral feeding devices market [1] - The analysis is based on cash flow statements and unlevered free cash flow figures, with a focus on historical financial data and future forecasts [1] Group 2 - The article emphasizes the importance of financial models that include various metrics such as cost of capital, cost of debt, WACC, share count, and net debt [1] - The author provides access to a database with over 15,000 DCF models ranked by margin of safety and upside potential [1]